Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 7/20 | 0.54 |
| ▸ | RAB9A | P51151 | 7/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.54 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 13/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | UBE2N | P61088 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25916602 | 0.83 | FSCN1 (0.42) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL25916808 | 0.80 | MAPT (0.50) | NPC1RAB9ASMN1; SMN2TP53LMNA | |
| SCHEMBL25916693 | 0.77 | MAPT (0.55) | NPC1RAB9ASMN1; SMN2TP53LMNA | |
| SCHEMBL17696371 | 0.71 | AGPAT2 (0.52) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL12351738 | 0.71 | RAB9A (1.00) | NPC1RAB9ASMN1; SMN2TP53LMNA | |
| SCHEMBL25916611 | 0.71 | TP53 (0.55) | NPC1RAB9ASMN1; SMN2TP53LMNA | |
| SCHEMBL22259647 | 0.69 | APP (0.62) | NPC1RAB9ASMN1; SMN2TP53LMNA | |
| SCHEMBL9296366 | 0.69 | KDM4E (0.60) | NPC1RAB9ASMN1; SMN2TP53LMNA | |
| SCHEMBL29478093 | 0.68 | MAPT (0.61) | NPC1RAB9ASMN1; SMN2TP53LMNA | |
| SCHEMBL28385011 | 0.68 | MAPT (0.61) | NPC1RAB9ASMN1; SMN2TP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230235190-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | Crime Science Technology (FR) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230235190-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | TUBB3, TUBA3C, PHB1 | NPC1 1326/4885RAB9A 3041/4885SMN1; SMN2 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.